Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 10784

1.

Less is more--possible option in the treatment of depression.

Dadić-Hero E, Knez R, Rebić J.

Coll Antropol. 2014 Dec;38(4):1207-9.

PMID:
25842759
2.

Relationship between internalized stigma and treatment efficacy in mixed neurotic spectrum and depressive disorders.

Ociskova M, Prasko J, Kamaradova D, Grambal A, Latalova K, Sigmundova Z.

Neuro Endocrinol Lett. 2014;35(8):711-7.

PMID:
25702300
3.

Clinical practice. Complicated grief.

Shear MK.

N Engl J Med. 2015 Jan 8;372(2):153-60. doi: 10.1056/NEJMcp1315618. Review. No abstract available.

PMID:
25564898
4.

Reversal of non-suppression of cortisol levels in a patient with refractory depression receiving ketamine.

Ostroff R, Kothari JS.

Am J Psychiatry. 2015 Jan;172(1):95-6. doi: 10.1176/appi.ajp.2014.14060776. No abstract available.

PMID:
25553498
5.
6.

Risk-benefit analysis of antidepressant drug treatment in the elderly.

Alamo C, López-Muñoz F, García-García P, García-Ramos S.

Psychogeriatrics. 2014 Dec;14(4):261-8. doi: 10.1111/psyg.12057. Review.

PMID:
25495088
7.

Impact of antidepressant therapy on cognitive aspects of work, condom use, and psychosocial well-being among HIV clients in Uganda.

Wagner GJ, Ngo VK, Nakasujja N, Akena D, Aunon F, Musisi S.

Int J Psychiatry Med. 2014;48(3):155-66. doi: 10.2190/PM.48.3.a.

PMID:
25492710
8.

Differences in quality of life outcomes among depressed spinal cord injury trial participants.

Tate DG, Forchheimer M, Bombardier CH, Heinemann AW, Neumann HD, Fann JR.

Arch Phys Med Rehabil. 2015 Feb;96(2):340-8. doi: 10.1016/j.apmr.2014.09.036. Epub 2014 Oct 22.

PMID:
25450124
9.

Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.

Cox GR, Callahan P, Churchill R, Hunot V, Merry SN, Parker AG, Hetrick SE.

Cochrane Database Syst Rev. 2014 Nov 30;11:CD008324. doi: 10.1002/14651858.CD008324.pub3. Review.

PMID:
25433518
10.

Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial.

Kim JM, Bae KY, Stewart R, Jung BO, Kang HJ, Kim SW, Shin IS, Hong YJ, Kim JH, Shin HY, Kang G, Ahn Y, Kim JK, Jeong MH, Yoon JS.

J Clin Psychiatry. 2015 Jan;76(1):62-8. doi: 10.4088/JCP.14m09281.

PMID:
25375836
11.

Antidepressants' black-box warning--10 years later.

Friedman RA.

N Engl J Med. 2014 Oct 30;371(18):1666-8. doi: 10.1056/NEJMp1408480. No abstract available.

12.
13.

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

Ionescu DF, Luckenbaugh DA, Niciu MJ, Richards EM, Slonena EE, Vande Voort JL, Brutsche NE, Zarate CA Jr.

J Clin Psychiatry. 2014 Sep;75(9):e932-8. doi: 10.4088/JCP.14m09049.

PMID:
25295436
14.

Effects of antidepressants and soybean association in depressive menopausal women.

Estrella RE, Landa AI, Lafuente JV, Gargiulo PA.

Acta Pol Pharm. 2014 Mar-Apr;71(2):323-7.

15.

A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.

Dunner DL, Aaronson ST, Sackeim HA, Janicak PG, Carpenter LL, Boyadjis T, Brock DG, Bonneh-Barkay D, Cook IA, Lanocha K, Solvason HB, Demitrack MA.

J Clin Psychiatry. 2014 Dec;75(12):1394-401. doi: 10.4088/JCP.13m08977.

16.

Clinical practice. Depression in the elderly.

Taylor WD.

N Engl J Med. 2014 Sep 25;371(13):1228-36. doi: 10.1056/NEJMcp1402180. Review. No abstract available.

17.

Venlafaxine, paroxetine and milnacipran for major depressive disorder: a pragmatic 24-week study.

Chuang HY, Chang YH, Cheng LY, Wang YS, Chen SL, Chen SH, Chu CH, Lee IH, Chen PS, Yeh TL, Yang YK, Lu RB.

Chin J Physiol. 2014 Oct 31;57(5):265-70. doi: 10.4077/CJP.2014.BAC209.

PMID:
25241986
18.

A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine.

Deardorff WJ, Grossberg GT.

Expert Opin Pharmacother. 2014 Dec;15(17):2525-42. doi: 10.1517/14656566.2014.960842. Epub 2014 Sep 16. Review.

PMID:
25224953
19.

[Electroconvulsion therapy for neuroleptic malignant syndrome].

Buggenhout S, Vandenberghe J, Sienaert P.

Tijdschr Psychiatr. 2014;56(9):612-5. Dutch.

20.

Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment.

Schoeyen HK, Kessler U, Andreassen OA, Auestad BH, Bergsholm P, Malt UF, Morken G, Oedegaard KJ, Vaaler A.

Am J Psychiatry. 2015 Jan;172(1):41-51. doi: 10.1176/appi.ajp.2014.13111517. Epub 2014 Oct 31.

PMID:
25219389
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk